Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|May 18, 2007
Novel role for insulin as an autocrine growth factor for malignant brain tumour cellsAlexandre Arcaro, Kathrin T Doepfner, Danielle Boller, et al.
European Journal of Immunology|October 16, 2007
Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic childrenSonja Junge, Barbara Kloeckener-Gruissem, Romain Zufferey, et al.
Molecular Cancer Therapeutics|January 8, 2010
Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTDTarek Shalaby, André O von Bueren, Marie-Louise Hürlimann, et al.
Molecular Cancer Research : MCR|June 10, 2011
A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistanceAna S Guerreiro, Sarah Fattet, Dorota W Kulesza, et al.
Journal of Neuro-Oncology|September 8, 2010
Expression of O⁶-methylguanine-DNA methyltransferase in childhood medulloblastomaDenis Faoro, André O von Bueren, Tarek Shalaby, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|July 12, 2017
Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment responseCarsten Friedrich, Tarek Shalaby, Christoph Oehler, et al.
Molecular Cancer Therapeutics|October 5, 2010
The quassinoid derivative NBT-272 targets both the AKT and ERK signaling pathways in embryonal tumorsDeborah Castelletti, Giulio Fiaschetti, Valeria Di Dato, et al.
BMC Cancer|February 18, 2011
c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patientsAndré O von Bueren, Christoph Oehler, Tarek Shalaby, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91Stefan Rutkowski, André von Bueren, Katja von Hoff, et al.
Anticancer Research|July 31, 2012
Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumoursDanielle Boller, Kathrin T Doepfner, Angela De Laurentiis, et al.
Pageof 4